Gene · 5892
Papers2,681
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,681
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The APOBEC3B c.783delG Truncating Mutation Is Not Associated with an Increased Risk of Breast Cancer in the Polish Population. | Genes (Basel) | 2023 | 37510234 | PubTator, text mining | PubMed |
| Heterozygous Pathogenic Nonsense Variant in the ATM Gene in a Family with Unusually High Gastric Cancer Susceptibility. | Biomedicines | 2023 | 37509701 | PubTator, text mining | PubMed |
| Unravelling the Role of PARP1 in Homeostasis and Tumorigenesis: Implications for Anti-Cancer Therapies and Overcoming Resistance. | Cells | 2023 | 37508568 | PubTator, text mining | PubMed |
| Next-Generation Sequencing Technology: Current Trends and Advancements. | Biology (Basel) | 2023 | 37508427 | PubTator, text mining | PubMed |
| Germline Mutations in 12 Genes and Risk of Ovarian Cancer in Three Population-Based Cohorts. | Cancer Epidemiol Biomarkers Prev | 2023 | 37493628 | PubTator, text mining | PubMed |
| RAD51C-XRCC3 structure and cancer patient mutations define DNA replication roles. | Nat Commun | 2023 | 37488098 | PubTator, text mining | PubMed |
| The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma. | Nat Commun | 2023 | 37474499 | PubTator, text mining | PubMed |
| Landscape of germline pathogenic variants in patients with dual primary breast and lung cancer. | Hum Genomics | 2023 | 37461096 | PubTator, text mining | PubMed |
| Evaluating ChatGPT as an adjunct for the multidisciplinary tumor board decision-making in primary breast cancer cases. | Arch Gynecol Obstet | 2023 | 37458761 | PubTator, text mining | PubMed |
| The evolving role of DNA damage response in overcoming therapeutic resistance in ovarian cancer. | Cancer Drug Resist | 2023 | 37457127 | PubTator, text mining | PubMed |
| Targeting the stimulator of interferon genes (STING) in breast cancer. | Front Pharmacol | 2023 | 37448962 | PubTator, text mining | PubMed |
| Selective Killing of BRCA2-Deficient Ovarian Cancer Cells via MRE11 Blockade. | Int J Mol Sci | 2023 | 37446144 | PubTator, text mining | PubMed |
| Mesenchymal Stem Cell Conditioned Medium Modulates Inflammation in Tenocytes: Complete Conditioned Medium Has Superior Therapeutic Efficacy than Its Extracellular Vesicle Fraction. | Int J Mol Sci | 2023 | 37446034 | PubTator, text mining | PubMed |
| Overview of the Genetic Causes of Hereditary Breast and Ovarian Cancer Syndrome in a Large French Patient Cohort. | Cancers (Basel) | 2023 | 37444530 | PubTator, text mining | PubMed |
| Spectrum and Frequency of Germline FANCM Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases. | Cancers (Basel) | 2023 | 37444426 | PubTator, text mining | PubMed |
| Impact of DNA damage repair alterations on prostate cancer progression and metastasis. | Front Oncol | 2023 | 37434977 | PubTator, text mining | PubMed |
| Meeting abstracts from the Annual Conference "Clinical Genetics of Cancer 2022". | Hered Cancer Clin Pract | 2023 | 37434214 | PubTator, text mining | PubMed |
| Emerging Necessity of Myeloid Mutational Analysis in Early T-cell Precursor Acute Lymphoblastic Leukemia/Lymphoma (ETP-ALL) | Turk J Haematol | 2023 | 37431282 | PubTator, text mining | PubMed |
| Update on poly(ADP-ribose) polymerase inhibitors resistance in ovarian cancer. | Front Pharmacol | 2023 | 37426808 | PubTator, text mining | PubMed |
| Homologous recombination pathway gene variants identified by tumor-only sequencing assays in lung carcinoma patients. | Transl Lung Cancer Res | 2023 | 37425424 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5892/papers?page=19